🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2026-525176-26-00
Authorised Phase I

Study to Learn How Safe EV25 is and the Amount of EV25 in the Body Over a Period of Time, When Given as a Single Dose to Adult Healthy People [CCI]

2026-525176-26-00 · tracked via the Priya Life Science EU tracker
Sponsor
Eradivir Inc.
Sponsor type
Pharmaceutical company
Therapeutic area
Virus Diseases
Decision date
30/04/2026
Enrollment target
16
Sites
Belgium

Condition studied

Influenza

Eligibility

Age group
65+ years, 18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2026-525176-26-00 on CTIS ↗ ← All trials in the EU